Cargando…
Inhibition of Mitochondrial p53 Accumulation by PFT-μ Prevents Cisplatin-Induced Peripheral Neuropathy
Chemotherapy-induced peripheral neuropathy (CIPN), a debilitating major side effect of cancer treatment, is characterized by pain and sensory loss in hand and feet. Platinum-based chemotherapeutics like cisplatin frequently induce CIPN. The molecular mechanism underlying these neurotoxic symptoms is...
Autores principales: | Maj, Magdalena A., Ma, Jiacheng, Krukowski, Karen N., Kavelaars, Annemieke, Heijnen, Cobi J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394177/ https://www.ncbi.nlm.nih.gov/pubmed/28458631 http://dx.doi.org/10.3389/fnmol.2017.00108 |
Ejemplares similares
-
The Anti-Diabetic Drug Metformin Protects against Chemotherapy-Induced Peripheral Neuropathy in a Mouse Model
por: Mao-Ying, Qi-Liang, et al.
Publicado: (2014) -
Mitochondrial transfer from mesenchymal stem cells to neural stem cells protects against the neurotoxic effects of cisplatin
por: Boukelmoune, Nabila, et al.
Publicado: (2018) -
Metformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in Mice
por: Zhou, Wenjun, et al.
Publicado: (2016) -
Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment
por: Ma, Jiacheng, et al.
Publicado: (2018) -
Astrocytes rescue neuronal health after cisplatin treatment through mitochondrial transfer
por: English, Krystal, et al.
Publicado: (2020)